Research graph
References from Prognostic potential of integrated morphologic and metabolic parameters of pre-therapeutic [18F]FDG-PET/CT regarding progression-free survival (PFS) and overall survival (OS) in NSCLC-patients. Local targets link to admitted publications; unresolved targets remain external evidence.
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
10.3322/caac.21660 · 2021 · External reference
Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and MortalityA Global Analysis
10.1016/j.chest.2021.12.655 · 2022 · External reference
Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study
10.2196/43651 · 2023 · External reference
Unresolved reference
2018 · External reference
PET and PET-CT of lung cancer
10.1007/978-1-61779-062-1_3 · 2011 · External reference
Present and future roles of FDG-PET/CT imaging in the management of lung cancer
10.1007/s11604-016-0546-2 · 2016 · External reference
FDG PET/CT in the Staging of Lung Cancer
10.2174/1874471013666191223153755 · 2020 · External reference
Unresolved reference
External reference
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆)
10.1016/j.annonc.2021.03.207 · 2021 · External reference
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
10.1016/j.annonc.2022.12.013 · 2023 · External reference
Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer
10.1148/rg.2018180060 · 2018 · External reference
Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study
10.21873/anticanres.13255 · 2019 · External reference
Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer
10.21037/jtd.2018.01.148 · 2018 · External reference
Prognosis of recurrence after complete resection in early-stage non-small cell lung cancer
10.5090/kjtcs.2013.46.6.449 · 2013 · External reference
Cancer treatment and survivorship statistics, 2022
10.3322/caac.21731 · 2022 · External reference
The role of PET/CT as a prognosticator and outcome predictor in lung cancer
10.1586/17476348.2016.1147959 · 2016 · External reference
Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ((18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC)
10.1007/s00259-009-1291-x · 2010 · External reference
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection
10.1200/jco.2004.11.109 · 2004 · External reference
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer
10.1200/jco.2005.06.129 · 2005 · External reference
FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients
10.1016/j.lungcan.2006.09.010 · 2007 · External reference
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
10.1001/jama.2013.281053 · 2013 · External reference
Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen
2007 · External reference
Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy
10.1053/j.sult.2010.10.001 · 2010 · External reference
Reliability of SUVmax vs. SUVmean in FDG PET/CT
2009 · External reference
RECIST 1.1-Update and clarification: From the RECIST committee
10.1016/j.ejca.2016.03.081 · 2016 · External reference
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature
2023 · External reference
Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus
10.1007/s11307-008-0169-9 · 2009 · External reference
FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei
10.1007/s00259-016-3347-z · 2016 · External reference
Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma
10.1200/jco.2007.14.3628 · 2008 · External reference
Histologic coagulative tumour necrosis as a prognostic indicator of aggressiveness in renallung, thyroid and colorectal carcinomas: A brief review
10.3892/ol.2011.420 · 2012 · External reference
Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors
10.3348/kjr.2020.0454 · 2021 · External reference
Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables
10.1016/s0169-5002(02)00172-1 · 2002 · External reference
